Otsuka Holdings Co., Ltd.: Stomach Neoplasms trials

The registry lists 13 Stomach Neoplasms studies with Otsuka Holdings Co., Ltd. as lead sponsor. 1 are open to participants now and 5 have results posted.

Phase 1 2Phase 2 4Phase 3 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• AB122 Platform StudyRecruitingNCT04999761Phase 1
• Futibatinib in Patients With Specific FGFR AberrationsTerminatedNCT04189445Phase 2Results posted
• Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric CancerCompletedNCT02500043Phase 3Results posted
• Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric CancerCompletedNCT02322593Phase 3Results posted
• Diffuse Gastric and Esophagogastric Junction Cancer S-1 TrialTerminatedNCT01285557Phase 3Results posted
• A Safety and Efficacy Study in Patients With Gastric CancerCompletedNCT00400179Phase 3Results posted
• Phase II Study of ABI-007 for Gastric CancerCompletedNCT00661167Phase 2
• Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric CancerCompletedNCT00202969Phase 3
• A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC)CompletedNCT00152243Phase 3
• Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)CompletedNCT00152217Phase 3
• Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric CancerCompletedNCT00150670Phase 3
• Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric CancerCompletedNCT00072787Phase 1/2
• Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During SurgeryStatus unknownNCT00005876Phase 2